Axtria Ignite 2025: Madhavi Ramakrishna on leadership, cultu...
GSK's Madhavi Ramakrishna was the recipient of one of the annual Axtria Ignite Leadership Awards presented at the invite-only summit.
Digital marketing worked. Now pharma must reorganise around ...
Remember when I said that patients are coming to doctors with formed opinions – if they come to physicians at all?
Xenotransplantation at the brink of breakthrough: A new era ...
In a landmark procedure performed at Massachusetts General Hospital (MGH) on 25th January 2025, a 66-year-old man with end-stage renal disease (ESRD) received a genetically modif
More good news in Sjogren's as RemeGen trial delivers
A second new drug, RemeGen's telitacicept, has shown efficacy in a phase 3 Sjögren's syndrome trial in the space of a week.
Featured Content
Editor's Picks
Editor's Picks
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
LEAP TA: Life Sciences
Reimagine Hiring Tactics to Compete for the Best Life Sciences Talent
MASH Drug Development Summit
Advancing Efficacious MASH Therapeutics in the Evolving Metabolic Landscape
2nd World Companion Diagnostics & Liquid Biopsy Summit APAC
The Asia-Pacific region is becoming a rising player in the co-development and commercialization of drug-diagnostic strategies
10th CAR-TCR Summit – A Decade of Engineering a Disease-Free...
It's a pivotal moment for cell therapy. New trials, breakthrough data, major acquisitions and regulatory shifts are transforming the landscape...
LEAN Cell & Gene Summit Boston
Manufacturing Advanced Therapies Just in Time for All Patients